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ORIGINAL ARTICLE
Patients with psychological ICPC codes in primary care; a case-control study
investigating the decade before presenting with problems
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aResearch Institute CAPHRI, Department of Family Medicine, Maastricht University, Maastricht, The Netherlands; bDepartment of
Community Medicine, Tromso University, Tromso, Norway; cDepartment of Public Health, Mekelle University, Mekelle, Ethiopia
KEY MESSAGES
 General practitioners can have problems with recognizing psychological problems.
 The use of electronic medical records (EMR) data could be an interesting option for timely recognition.
 Patients who presented with psychological problems showed a different medical history than patients who
did not. These results could help GPs be more attentive to possible indications of psychological problems.
ABSTRACT
Background: Recognizing patients with psychological problems can be difficult for general prac-
titioners (GPs). Use of information collected in electronic medical records (EMR) could facilitate
recognition.
Objectives: To assess relevant EMR parameters in the decade before patients present with psy-
chological problems.
Methods: Exploratory case-control study assessing EMR parameters of 58 228 patients recorded
between 2013 and 2015 by 54 GPs. We compared EMR parameters recorded before 2014 of
patients who presented with psychological problems in 2014 with those who did not.
Results: In 2014, 2406 patients presented with psychological problems. Logistic regression analy-
ses indicated that having registrations of the following statistically significant parameters
increased the chances of presenting with psychological problems in 2014: prior administration of
a depression severity questionnaire (odds ratio (OR): 3.3); fatigue/sleeping (OR: 1.6), neurological
(OR: 1.5), rheumatic (OR: 1.5) and substance abuse problems (OR: 1.5); prescriptions of opioids
(OR: 1.3), antimigraine preparations (OR: 1.5), antipsychotics (OR: 1.7), anxiolytics (OR: 1.4), hyp-
notics and sedatives (OR: 1.4), antidepressants (OR: 1.7), and antidementia drugs (OR: 2.1); treat-
ment with minimal interventions (OR: 2.2) and physical exercise (OR: 3.3), referrals to psychology
(OR: 1.5), psychiatry (OR: 1.6), and psychosocial care (OR: 2.1); double consultations (OR: 1.2), tele-
phone consultations (OR: 1.1), and home visits (OR: 1.1).
Conclusion: This study demonstrates that possible indications of psychological problems can be
identified in EMR. Many EMR parameters of patients presenting with psychological problems
were different compared with patients who did not.
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Patients who suffer from psychological problems gen-
erate a significant burden on healthcare systems, espe-
cially primary care [1]. This burden consists of massive
healthcare consumption and high costs [2,3]. Patients
present with psychological symptoms at a later time
and less straightforward than most somatic symptoms,
which induces suboptimal recognition of psychological
problems in primary care [4,5]. Many general practi-
tioners (GPs) admit struggling with management of
psychological problems [6,7].
To control this healthcare burden, a considerable
body of research has focussed on the optimization of
diagnosis and treatment of people who present with
psychological problems in primary care [8,9].
Arguably, a more proactive and preventive
approach could lead to patients with less severe
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symptoms, better treatment outcomes and lower cost
development, in primary and in secondary care since
adequate treatment is cost-effective and reduces the
burden of disease [10]. Early and proactive recognition
and treatment of patients with psychological problems
have previously shown to reduce disease onset, symp-
tom levels and relapse, and improve treatment adher-
ence, social behaviour, work productivity and
absenteeism [11]. In this approach, patients should be
identified as cases of interest before actually present-
ing with problems. Routine screening of all patients in
primary care for psychological problems using ques-
tionnaires seems neither feasible nor desirable [12].
The use of data already routinely collected in elec-
tronic medical records (EMR), appears a more interest-
ing option [13].
The identification of EMR parameters useful for
such an approach first requires a better understanding
of the period before patients present with psycho-
logical problems. Therefore, we assessed relevant EMR
parameters in a large group of primary care patients
during the decade before presenting with problems.
Methods
Design
An exploratory case-control study assessing relevant
EMR parameters of a population of 58 228 patients
recorded between 2003 and 2015 by 54 GPs. We com-
pared the EMR parameters recorded before 2014 of
patients who presented with relevant psychological
problems in 2014 with those who did not.
Setting
The Eindhoven Corporation of Primary Health Care
Centres (Stichting Gezondheidscentra Eindhoven
(SGE)), which includes 10 multidisciplinary primary
healthcare centres in Eindhoven, the Netherlands.
During the study period, 54 different GPs were
employed, ranging from 38 in 2003 to 47 in 2014.
Data collection
Since 2003, these healthcare centres used the same
digital information system for their EMR (Medicom,
Pharmapartners, Oosterhout). Data were extracted and
analysed in IBM SPSS Statistics for all patients of all
ages registered at any time in the study period from
July 2003 until January 2015. All patient information
was extracted anonymously and only regarding
patients who had previously given their permission for
the analyses of their EMR for research purposes.
Regarding data quality, our previous publications per-
taining to this setting showed high registration quality
[14,15].
Identification of two groups of patients
We identified patients presenting with relevant psycho-
logical problems as those patients for whom the GPs
registered one or more of the following psychological
codes from the international classification of primary
care (ICPC-1) as reason for encounter in 2014: feeling
anxious (P01), acute stress reaction (P02), post-traumatic
stress disorder (P02.01), feeling depressed (P03), feeling
angry (P04), other organic psychosis (P71), delirium
(P71.04), schizophrenia (P72), affective psychosis (P73),
bipolar disorder (P73.02), anxiety disorder (P74), panic
disorder (P74.01), generalized anxiety disorder (P74.02),
hypochondria (P75), depression (P76), postpartum
depression (P76.01), suicide attempt (P77), suicide
attempt (P77.01), suicide (P77.02), neurasthenia/surmen-
age (P78) mental exhaustion, neurosis (P79), phobia
(P79.01), obsessive-compulsive disorder (P79.02), per-
sonality disorder (P80), borderline personality disorder
(P80.01), other psychosis (P98) and burnout (Z29.01);
and named these ‘P-cases.’ The group of ‘non-P-cases’
consisted of those who were registered patients at any
time in 2014 but did not receive one or more of these
ICPC codes as reason for encounter in 2014. From these
two groups, we excluded 12 311 patients who had one
or more of these ICPC codes before 2014.
Relevant care parameters
For both groups, we identified demographics, adminis-
trations of the 4-dimensional symptom questionnaire
(4DSQ) and Beck depression inventory-2 (BDI2), previ-
ous morbidity (Supplementary Table 1), pharmacother-
apy, other treatments, referrals, and consumption of
GP services [16].
Demographics included gender, age on 1 January
2015, duration as registered patients between July
2003 and January 2014, civil status and socio-eco-
nomic status (SES). SES was based on status scores
derived from postal codes by the Netherlands Institute
for Social Research [17,18]. The scores were based on
average income, the percentage of people with low
income, the percentage of people with a lower educa-
tional level and the percentage of people that did not
work, per postal code. The Netherlands Institute for
Social Research calculated these scores since 1998 and
the average score over the period 1998–2014 was
zero. The SES scores were defined as the standard
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deviation (SD) surrounding the average score in
1998–2014. The average SES score in 2014 was 0.28.
All parameters hereafter have been assessed for the
period 1 July 2003 until 1 January 2014.
The 4DSQ is a patient questionnaire that assesses
distress, anxiety, depression and somatization and was
recommended in the Dutch primary care guidelines
for anxiety and depression [16,19–21]. The BDI2 is a
psychometric questionnaire to measure the severity of
depression and has been used as a required monitor-
ing tool for depression treatment progress in this set-
ting since 2008 [14,22]. For both questionnaires, we
calculated the number of administrations per patient
and the median scores per scale for all
administrations.
To measure previous morbidity, we grouped rele-
vant ICPC-1 codes into clusters of conditions
(Supplementary Table 1). A patient was defined as suf-
fering from a condition cluster when a patient had
one or more registrations of ICPC codes from such a
cluster between July 2003 and January 2014. We calcu-
lated the number of ICPC episodes and median epi-
sode duration for all patients.
Prescriptions for medication by the GPs were ana-
lysed for all subgroups of the Anatomical Therapeutic
Chemical (ATC) Classification System ‘nervous system’
(‘N’) chapter. Prescriptions were defined as separate
when there were more than seven days between
them. The median number of prescriptions and days
per prescription were calculated for all patients.
Relevant non-pharmacological treatment and refer-
ral options included dietary care, minimal interven-
tions, physical exercise, psychology, psychiatry and
psychosocial care. The minimal interventions included
brief counselling, bibliotherapy, mindfulness, psycho-
education, problem-solving therapy, or referral to a
social worker. Physical exercise therapies involved run-
ning therapy, physiotherapy, manual therapy and
Cesar therapy. Psychosocial care consisted of clinics for
alcohol and drugs counselling, complex psychosocial
care, regional institutes for outpatient mental
healthcare, psychogeriatrics, and social psychiatric
nurses. The median number of referrals was calculated
for all patients.
Consumption of GP services was calculated by total-
ling the number of office consultations with GPs or
practice nurses, telephone consultations, and home
visits for all patients.
Statistical analysis
All medians were calculated based on the patients
who had a registration of a specific parameter. p-val-
ues to assess whether the groups were significantly
different were calculated with Pearson’s chi square
tests and independent samples Mann–Whitney U tests.
Besides these bivariate analyses, we also performed
a logistic regression analysis per table, calculating odds
ratios for the separate factors in the tables in relation to
the outcome; presenting with relevant psychological
problems in 2014. All factors were used as categorical
factors in the regressions (e.g. presence of specific mor-
bidity or being referred before 2014, yes/no) excepting
consumption of GP services, for which the continuous
median consumption per year was used.
Results
In 2014, there were 2406 (4.1%) P-cases who had an
EMR registration of one or more relevant ICPC codes
as reason for encounter. There were 55 822 (95.9%)
non-P-cases in 2014. In the Supplementary tables
(available online), we present more detailed results.
Demographics
Table 1 shows the demographics of the two groups.
The patients registered with a relevant ICPC code in
2014 were more often female and older. They also had
lower SES scores. Although the groups differed signifi-
cantly (p-value <.05) in median duration as registered
Table 1. Demographics.
P-cases n¼ 2406 (4.1%) Non-P-cases n¼ 55 822 (95.9%) p-value
Female 60.7% 48.1% <.05
Median age 1 January 2015 (IQR) 38.9 (27.8–55.3) 36.6 (18.6–57.2) <.05
Median duration as registered patient (IQR) 10.5 (4.7–10.5) 9.4 (3.8–10.5) <.05
Civil state <.05





Median socio-economic status score (IQR) 0.38 SD (0.59 to 0.64) 0.30 SD (0.54 to 0.96) <.05
IQR: interquartile range.
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patients, these medians were comparable for both
groups.
Mental health questionnaires
Of the 2406 P-cases, six patients (0.2%) were adminis-
tered the 4DSQ and 28 (1.2%) the BDI2 before 2014
(Supplementary Table 2). The (sub) scores on both
questionnaires were similar. In the logistic regression,
administrations of both questionnaires were included
as categorical factors. We found that patients who had
a BDI2 administration before 2014 had significantly
higher chances of presenting relevant psychological
problems in 2014 (OR: 3.3, p-value <.05) compared
with those who did not fill in a BDI2.
Previous morbidity
As to previous morbidity in Table 2, all but two condi-
tion clusters were present at higher rates in the
P-cases as opposed to the non-P-cases before 2014.
Episode duration did not seem to differ between the
two groups (Supplementary Table 3). The median
number of episodes per patient was one for all listed
conditions for both groups (IQR 1–1).
The logistic regression analysis with all morbidity
clusters presented in Table 2 included, showed that
prior episodes of fatigue/sleeping, neurological,
rheumatic and substance abuse problems significantly
increased the chances of presentation with psycho-
logical problems in 2014.
Pharmacotherapy
Nervous system medications were prescribed for a
substantial part of the P-cases, especially opioids
(11%), other analgesics and antipyretics (10%), anxio-
lytics (12%) and hypnotics and sedatives (10%)
(Table 3). All prescribed nervous system medication
groups were prescribed more often to P-cases before
Table 2. Morbidity before 2014. The median N episodes per patient were one for all listed conditions for both groups (IQR 1–1).
Bivariate analysis
Logistic regressiona
Condition clusters P-cases n¼ 2406 n, (%) Non-P-cases n¼ 55 822 n, (%) p-value OR (95%CI) p-value
Cancer 133 (5.5) 3206 (5.7) .656 0.9 (0.7–1.1) .248
Cardiovascular disease 361 (15.0) 8195 (14.7) .661 0.9 (0.8–1.0) .075
Fatigue/sleeping disorders 386 (16.0) 5634 (10.1) <.05 1.6 (1.4–1.8) <.05
Irritable bowel disease 14 (0.6) 386 (0.7) .524 0.8 (0.4–1.3) .307
Metabolic/eating disorders 226 (9.4) 4412 (7.9) <.05 1.1 (1.0–1.3) .082
Neurological disorders 178 (7.4) 2616 (4.7) <.05 1.5 (1.3–1.8) <.05
Respiratory disorders 145 (6.0) 3012 (5.4) .181 1.0 (0.8–1.2) .933
Rheumatic disorders 46 (1.9) 667 (1.2) <.05 1.5 (1.1–2.0) <.05
Substance abuse 203 (8.4) 3133 (5.6) <.05 1.5 (1.3–1.7) <.05
OR: odds ratio; 95%CI: 95% confidence interval.
aLogistic regression analysis with being a ‘P-case’ as dependent variable and having 1 ICPC codes from the separate condition clusters as dichotomous
independent variables. Table 1 in the Supplementary provides an overview of the ICPC codes in the separate condition clusters.
Table 3. Nervous system medication before 2014. Unlisted ATC ‘N’ groups were not prescribed.
Bivariate analysis
Logistic regressionb
ATC groups P-cases n¼ 2406 n (%) Non-P-cases n¼ 55 822 n (%) p-value OR (95%CI) p-value
General anaesthetics (N01A)a 1 (0) 1 (0) <.05
Local anaesthetics (N01B) 136 (5.7) 2859 (5.1) .248 0.9 (0.8–1.1) .469
Opioids (N02A) 253 (10.5) 3549 (6.4) <.05 1.3 (1.1–1.5) <.05
Other analgesics and antipyretics (N02B) 243 (10.1) 4175 (7.5) <.05 1.0 (0.9–1.2) .903
Antimigraine preparations (N02C) 98 (4.1) 1241 (2.2) <.05 1.5 (1.2–1.9) <.05
Anti-epileptics (N03A) 54 (2.2) 794 (1.4) <.05 0.9 (0.7–1.3) .726
Anticholinergic agents (N04A)a 0 (0) 9 (0) .533
Dopaminergic agents (N04B) 18 (0.7) 184 (0.3) <.05 1.4 (0.9–2.4) .164
Antipsychotics (N05A) 23 (1.0) 195 (0.3) <.05 1.7 (1.1–2.6) <.05
Anxiolytics (N05B) 284 (11.8) 3.666 (6.6) <.05 1.4 (1.3–1.7) <.05
Hypnotics and sedatives (N05C) 237 (9.9) 2.944 (5.3) <.05 1.4 (1.2–1.7) <.05
Antidepressants (N06A) 132 (5.5) 1.245 (2.2) <.05 1.7 (1.4–2.1) <.05
Psychostimulants (N06B) 12 (0.5) 256 (0.5) .776 1.0 (0.5–1.8) .953
Antidementia drugs (N06D) 12 (0.5) 93 (0.2) <.05 2.1 (1.1–3.9) <.05
Parasympathomimetics (N07A)a 1 (0) 8 (0) .293
Drugs used in addictive disorders (N07B) 53 (2.2) 779 (1.4) <.05 1.2 (0.9–1.6) .173
Anti-vertigo preparations (N07C) 66 (2.7) 1.114 (2.0) <.05 1.0 (0.8–1.3) .940
Other nervous system drugs (N07X)a 1 (0) 1 (0) <.05
aATC groups were excluded from logistic regression analysis due to insufficient patients.
bLogistic regression analysis with being a ‘P-case’ as dependent variable and having 1 prescriptions from the separate ATC groups as dichotomous inde-
pendent variables.
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2014. The differences in durations per prescription
were not clinically relevant (Supplementary Table 4).
The logistic regression analysis indicated that opioids
(OR: 1.3), antimigraine preparations (OR: 1.5), antipsy-
chotics (OR: 1.7), anxiolytics (OR: 1.4), and hypnotics
and sedatives (OR: 1.4), antidepressants (OR: 1.7) and
antidementia drugs (OR: 2.1) significantly increased the
chances of presentation with psychological problems
in 2014.
Other treatments and referrals
The P-cases were referred at statistically significant
higher rates to minimal interventions, physical exer-
cise, psychology, psychiatry and psychosocial care
(Table 4). A prior referral to one of these also signifi-
cantly increased the chances of presenting with a psy-
chological problem in 2014.
Consumption of GP services
Table 5 shows that fewer P-cases had consultations
with their GPs than non-P-cases (69% versus 80%) and
less had telephone consultations (61% versus 64%). Yet,
they consumed the other types of healthcare activities
more often. Although the rates of consumption of GP
services were quite similar, the P-cases seemed to con-
sume more of all care types per year. The logistic
regression analysis showed that having one more con-
sultation with the GP decreased the chance of presen-
tation with psychological problems in 2014 (OR: 0.96 p-
value <.05). Consuming more double consultations,
telephone consultations or home visits significantly
increased these chances, although these odds ratios
remained small (1.19, 1.06 and 1.14, respectively).
Discussion
Main findings
Patients who presented with psychological problems
(i.e. ‘P-cases’) in 2014 showed significantly higher rates
of BDI2 administrations, episodes of fatigue/sleeping,
metabolic/eating, neurological, rheumatic and substance
abuse problems, several nervous system medication
group prescriptions, all treatment and referral options
except dietary care, double consultations and home vis-
its before 2014 compared with the non-P-cases.
Interpretation of findings
Demographics
The median durations as registered patients were vast
and comparable for both groups (9–10 years). This
enhanced comparability of both groups i.e. the win-
dows of opportunity in which GPs could register
parameters of interest was equal.
Previous morbidity
Our study produced parameters that significantly
increased the chances of presenting with relevant psy-
chological problems in 2014. Concerning previous
Table 4. Treatments/referrals before 2014.
Bivariate analysis
Logistic regressiona
Treatments/referrals P-cases n¼ 2406 n (%) Non-P-cases n¼ 55 822 n (%) p-value OR (95%CI) p-value
Dietary care 100 (4.2) 2042 (3.7) .204 1.0 (0.8–1.3) .841
Minimal interventions 128 (5.3) 1199 (2.1) <.05 2.2 (1.8–2.7) <.05
Physical exercise therapies 456 (19.0) 9092 (16.3) <.05 1.1 (1.0–1.2) <.05
Psychology 192 (8.0) 2649 (4.7) <.05 1.5 (1.3–1.7) <.05
Psychiatry 53 (2.2) 626 (1.1) <.05 1.6 (1.2–2.1) <.05
Psychosocial care 22 (0.9) 191 (0.3) <.05 2.1 (1.4–3.3) <.05
aLogistic regression analysis with being a ‘P-case’ as dependent variable and having 1 of the separate treatments/referrals as dichotomous independent
variables. The separate treatments/referrals are explained in the methods.
Table 5. Consumption of GP services before 2014.
Bivariate analysis
Logistic regressiona
Types of consumption P-cases n¼ 2406 Non-P-cases n¼ 55 822 p-value OR (95%CI) p-value
Consultations n¼ 1650 (68.6%) n¼ 44 362 (79.5%) <.05
Median N per patient per year (IQR) 2 (2–4) 2 (1–3) <.05 0.96 (0.93–0.99) <.05
Double consultations n¼ 1386 (57.6%) n¼ 30 521 (54.7%) <.05
Median N per patient per year (IQR) 1 (1–2) 1 (1–2) <.05 1.19 (1.14–1.24) <.05
Telephone consultations n¼ 1460 (60.7%) n¼ 35 559 (63.7%) <.05
Median N per patient per year (IQR) 2 (1–2) 1 (1–2) <.05 1.06 (1.02–1.10) <.05
Home visits n¼ 215 (8.9%) n¼ 3984 (7.1%) <.05
Median N per patient per year (IQR) 1 (1–2) 1 (1–1) <.05 1.14 (1.06–1.23) <.05
aLogistic regression analysis with being a ‘p-case’ as dependent variable and the median N per patient per year as continuous independent variables.
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morbidity, especially patients with fatigue/sleeping,
neurological, rheumatic and substance abuse problems
should warrant additional awareness from GPs of
(future) psychological problems in patients presenting
with these morbidities, which have already shown to
increase the risk of anxiety and depression, for
example [23,24].
Pharmacotherapy and other treatments and
referrals
Many of the medication groups and treatment and
referral options showed increased risk of presentation
with psychological problems, which could be because
these were psychology oriented and could be seen as
preliminary actions leading up to a relevant ICPC regis-
tration. A more in-depth analysis of prescribed medica-
tion and treatments is possible based on the EMR
used in this setting, i.e. including all ATC groups. For
this study, we chose only to assess psycho-medication
because of the number of results we already pre-
sented. Broadening the ATC scope would be interest-
ing and enhance the comparability of this setting with
other studies on medication associated with psycho-
logical problems [25].
Additionally, the P-cases were referred more often
to physical exercise therapies, possibly indicating that
the P-cases also had more lifestyle-orientated prob-
lems in their medical history.
Consumption of GP services
Besides the specific medical history of P-cases, they
consumed more double consultations and home visits
than non-P-cases. The P-cases also showed higher num-
bers in total and per year. Frequent re-attendance is an
established predictor of psychological problems [2,26].
In our results, this is reflected in the bivariate analyses
indicating higher numbers of all types of consumption
of GP services for the P-cases, both in total as well as
per year. Hence, it might seem odd that in the logistic
regression analysis, a higher number of consultations
per year was associated with a decreased chance
of presenting with psychological problems (OR: 0.96,
p-value <.05). However, this is compensated by the
results of the logistic regression analysis concerning the
other types of consumption of GP services. This is an
indication that P-cases had a different care pattern, see-
ing the GP more often and longer per contact moment.
Strengths and limitations
This study can be useful in showing the diversity
and usefulness of information incorporated in EMR.
EMR can provide clinical information of many patients
over an extended period, providing means to assess
usual care in everyday practice, without the workload
and drawbacks of research projects in which care pro-
viders and patients actively have to participate.
Although EMR can provide relevant data, some data
that would have been very interesting were missing in
our study. This is a difference between EMR research
and patient questionnaire research. For instance, social
and personal circumstances of the patients would
have been interesting and valuable, but were lacking
in our data. Previous research disclosed several socio-
economic factors that influenced the occurrence of
psychological problems, such as a civil state, SES,
functional impairment, social contacts, life events,
bereavement, ethnicity [23,24,27–29]. In the EMR we
assessed, (changes in) such factors were under regis-
tered or difficult to extract. Indeed, we included civil
state and SES, but the civil state of a significant per-
centage of patients was unknown and SES was a
proxy based on postal codes. This could be poten-
tially solved by more registration of such factors in
EMR or combining questionnaires and EMR assess-
ments in future research on predictors. This could
contribute to reducing the problem that few studies
on predictors and risk factors for psychological prob-
lems assess the same factors [24].
Factors that possibly predict the occurrence of psy-
chological problems have been described before
including female gender, lower SES, chronic condi-
tions, sleeping problems and disability, though to our
knowledge this is the first study to present different
usable parameters derived from EMR from one health-
care system [23,24,30]. Also, our results indicate that
predictors, previously found in research actively involv-
ing patients, can be found in EMR. Hypothetically,
other primary care practices could use our methods to
disclose relevant local EMR parameters with predictive
value concerning their particular population of
patients, to target their high-risk groups more
specifically.
Implications for practice
The large number of EMR parameters statistically sig-
nificantly associated with psychological problems indi-
cates that it is probably not possible to identify one or
two specific predictors but that it is much more a pal-
ette of comorbidity, use of medication and other
therapies, and frequent attendance that should induce
increased alertness from GPs and other primary care
providers. Moreover, this palette can be observed
when reviewing the EMR.
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Most of the associated parameters we found were
related to psychological problems. More unexpected,
non-psychological parameters included fatigue/sleep-
ing, neurological, rheumatic and substance abuse
problems, and physical exercise therapy.
Based on the presented parameters, primary care
providers could be supported in identifying patients
prone to present psychological problems in the future.
These patients could then be invited for a GP consult-
ation or offered a psychometric questionnaire in the
case of diagnostic uncertainty or to help the patient
gain insight.
Conclusions
This study demonstrates that possible indications of
psychological problems can be identified in EMR.
Patients who presented with psychological problems
to their GPs in 2014, showed large differences in their
EMR parameters in the decade before compared with
those who did not present with these problems.
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